This is available in:
- English
- 中文
Sidley Represented Eight Roads Ventures in Insilico Medicine's US$37 Million Series B Financing
October 11, 2019
Related Professionals
Stay Up To Date
Sidley represented Eight Roads Ventures as an investor in Insilico Medicine's US$37 million Series B funding round. Insilico Medicine is engaged in developing next-generation artificial intelligence technology for drug discovery. The financing round included Eight Roads Ventures, F-Prime Capital, Qiming Venture Partners, Lilly Asia Ventures, Sinovation Ventures, Baidu Ventures, Pavilion Capital, Bold Capital Partners and other Series A investors.
The Sidley team was led by partner Ruchun Ji (Shanghai and Palo Alto) with assistance from associate Henry Cao (Shanghai).
This website uses cookies. Analytical cookies help us improve our website by providing insight on how visitors interact with our site, and necessary cookies which the website needs to function properly.
Necessary Cookies
The website cannot function properly without these necessary cookies, and they can only be disabled by changing your browser preferences. To learn more about these cookies, how we use them on our website, and how to revise your cookie settings, please view our cookie policy.
You have successfully set your edition to United States. Would you like to make this selection your default edition?
*Selecting a default edition will set a cookie.
This website uses cookies. Analytical cookies help us improve our website by providing insight on how visitors interact with our site, and necessary cookies which the website needs to function properly.
Necessary Cookies
The website cannot function properly without these necessary cookies, and they can only be disabled by changing your browser preferences. To learn more about these cookies, how we use them on our website, and how to revise your cookie settings, please view our cookie policy.